4dmedical Ltd.

Major publication validates CTVQ for lung surgery

GSK contract, UK clearance for CTVQ, and ASX 200 inclusion

Insignia Financial to be removed from the S&P/ASX 200 Index

4DMedical receives CE Mark for CT:VQ™, enabling commercial launch across the European Union

CE Mark for CTVQ and $83M placement to fund EU expansion